Literature DB >> 14986008

Histological findings of a surgically excised myopic choroidal neovascular membrane after photodynamic therapy. A case report.

A Scupola1, L Ventura, A C Tiberti, D D'Andrea, E Balestrazzi.   

Abstract

BACKGROUND: The authors describe a myopic choroidal neovascular membrane excised 4 months after photodynamic therapy (PDT).
METHODS: A 68-year-old woman with classic choroidal neovascularization (CNV) due to pathologic myopia underwent PDT with verteporfin in the left eye. Four months after treatment a full-thickness macular hole was diagnosed in the same eye and the patient underwent vitrectomy with submacular membranectomy. The subfoveal membrane was studied by light microscopy and immunohistochemical techniques.
RESULTS: Light microscopy showed a thin fibrovascular membrane covered by residual retinal pigment epithelium. The membrane contained homogeneous matrix with small collagen bundles, fibroblasts and small blood vessels. The distribution of blood vessels was nonuniform: extravasated red blood cells, macrophages and other inflammatory elements were not present in the fibrous matrix. Endothelial cells were highlighted by CD34 immunostaining and did not show any significant alteration. There was no evidence of inflammatory cells or thrombosis inside vascular lumina.
CONCLUSIONS: Histologic examination of the neovascular membrane showed features similar to those of surgically excised myopic CNV without PDT treatment. Our findings suggest that PDT-induced occlusion is temporary. Fluorescein leakage from CNV after a single PDT treatment can be considered as an sign of blood vessel regrowth or recanalization indicating that multiple treatments are necessary.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14986008     DOI: 10.1007/s00417-004-0870-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  27 in total

1.  Agar melting with microwave.

Authors:  L Ventura; T Ventura
Journal:  Ophthalmology       Date:  2001-04       Impact factor: 12.079

2.  Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.

Authors: 
Journal:  Ophthalmology       Date:  2001-05       Impact factor: 12.079

3.  Well-defined subfoveal choroidal neovascular membranes in age-related macular degeneration.

Authors:  P F Lopez; H M Lambert; H E Grossniklaus; P Sternberg
Journal:  Ophthalmology       Date:  1993-03       Impact factor: 12.079

4.  Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples.

Authors:  U Schmidt-Erfurth; J Miller; M Sickenberg; A Bunse; H Laqua; E Gragoudas; L Zografos; R Birngruber; H van den Bergh; A Strong; U Manjuris; M Fsadni; A M Lane; B Piguet; N M Bressler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1998-05       Impact factor: 3.117

5.  Photochemical initiation of thrombosis. Fluorescein angiographic, histologic, and ultrastructural alterations in the choroid, retinal pigment epithelium, and retina.

Authors:  A J Royster; S K Nanda; D L Hatchell; J S Tiedeman; J J Dutton; M C Hatchell
Journal:  Arch Ophthalmol       Date:  1988-11

6.  Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.

Authors:  J W Miller; U Schmidt-Erfurth; M Sickenberg; C J Pournaras; H Laqua; I Barbazetto; L Zografos; B Piguet; G Donati; A M Lane; R Birngruber; H van den Berg; A Strong; U Manjuris; T Gray; M Fsadni; N M Bressler; E S Gragoudas
Journal:  Arch Ophthalmol       Date:  1999-09

7.  Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy.

Authors:  U E Schnurrbusch; K Welt; L C Horn; P Wiedemann; S Wolf
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

8.  A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes.

Authors:  M Sickenberg; U Schmidt-Erfurth; J W Miller; C J Pournaras; L Zografos; B Piguet; G Donati; H Laqua; I Barbazetto; E S Gragoudas; A M Lane; R Birngruber; H van den Bergh; H A Strong; U Manjuris; T Gray; M Fsadni; N M Bressler
Journal:  Arch Ophthalmol       Date:  2000-03

9.  Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy.

Authors:  Darius M Moshfeghi; Peter K Kaiser; Hans E Grossniklaus; Paul Sternberg; Jonathan E Sears; Mark W Johnson; Norman Ratliff; Andre Branco; Mark S Blumenkranz; Hilel Lewis
Journal:  Am J Ophthalmol       Date:  2003-03       Impact factor: 5.258

10.  Clinicopathologic features of surgically excised choroidal neovascular membranes.

Authors:  H E Grossniklaus; A K Hutchinson; A Capone; J Woolfson; H M Lambert
Journal:  Ophthalmology       Date:  1994-06       Impact factor: 12.079

View more
  3 in total

1.  Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.

Authors:  Wai-Man Chan; Timothy Y Y Lai; Amy L Wong; David T L Liu; Dennis S C Lam
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

2.  Optical coherence tomography to monitor photodynamic therapy in pathological myopia.

Authors:  A García-Layana; A Salinas-Alamán; M J Maldonado; C Sainz-Gómez; A Fernández-Hortelano
Journal:  Br J Ophthalmol       Date:  2006-02-07       Impact factor: 4.638

3.  Antiproliferative, Apoptotic, and Autophagic Activity of Ranibizumab, Bevacizumab, Pegaptanib, and Aflibercept on Fibroblasts: Implication for Choroidal Neovascularization.

Authors:  Lyubomyr Lytvynchuk; Andrii Sergienko; Galina Lavrenchuk; Goran Petrovski
Journal:  J Ophthalmol       Date:  2015-09-27       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.